Cumberland Pharmaceuticals (CPIX) Minority Interest (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Minority Interest across 17 years of filings, most recently posting -$333512.0 for Q1 2026.

• Minority Interest for Q1 2026 came in at -$333512.0, down 5.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$333512.0 (down 5.41% YoY), and the FY2025 annual result was -$336100.0, down 9.29% from the prior year.
• Minority Interest came in at -$333512.0 for Q1 2026 at Cumberland Pharmaceuticals, up from -$336100.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of -$229508.0 in Q1 2022 to a low of -$343572.0 in Q4 2023.
• The 5-year median for Minority Interest is -$312024.0 (2023), against an average of -$306871.5.
• Across the five-year window, Minority Interest tumbled 79.11% in 2022 and advanced 10.49% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Minority Interest stood at -$292126.0 in 2022, then dropped by 17.61% to -$343572.0 in 2023, then grew by 10.49% to -$307517.0 in 2024, then decreased by 9.29% to -$336100.0 in 2025, then climbed by 0.77% to -$333512.0 in 2026.
• The last three Minority Interest figures came in at -$333512.0 (Q1 2026), -$336100.0 (Q4 2025), and -$319150.0 (Q3 2025), per Business Quant data.